UCB (EBR:UCB) | Finanzwire

Basculer en Français

10387	Companies
216924	Keywords
146618	Articles
114861	Press releases

BRIEF

published on 12/08/2025 at 07:45, 5 months 4 days ago

UCB Reports Positive Phase 3 Trial Results for Fenfluramine in CDKL5 Disorder

UCB Phase 3 Study Fenfluramine CDKL5 Deficiency Seizure Reduction
PRESS RELEASE

published on 12/08/2025 at 07:40, 5 months 4 days ago

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
UCB presents positive results from GEMZ phase 3 study at AES showing significant reduction in countable motor seizure frequency in CDKL5 Deficiency Disorder. Study demonstrates efficacy and safety of fenfluramine as adjunctive treatment

AES UCB Fenfluramine Seizure Reduction GEMZ Phase 3 Study

Accesswire

Published on 05/12/2026 at 23:35, 29 minutes ago

Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 2 hours 9 minutes ago

UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 2 hours 22 minutes ago

Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 9 hours 34 minutes ago

Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 14:30, 9 hours 34 minutes ago

ACCESS Newswire Reports First Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 05/12/2026 at 23:47, 17 minutes ago

Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 1 hour 39 minutes ago

Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 3 hours 43 minutes ago

Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 4 hours 29 minutes ago

AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 4 hours 29 minutes ago

2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy

Les Echos

Published on 05/12/2026 at 18:15, 5 hours 49 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 5 hours 54 minutes ago

imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:45, 6 hours 19 minutes ago

imerys-12-05-2026-regulated-information-publication-of-the-report-on-payments-made-to-governments
Published on 05/12/2026 at 17:45, 6 hours 19 minutes ago

Financial information for the period ended 31 March 2026
Published on 05/12/2026 at 17:40, 6 hours 24 minutes ago

Eiffage acquires a majority stake in Hand & Werk to expand its presence in the German data centre market

View all LES ECHOS COMFI WIRE